InfuSystems Holdings Inc. Common Stock (INFU)

FairStock Score: 57/100 — STEADY

Key Financials

AI Analysis

AI-generated, general educational analysis — not personal investment advice.

At the 2026-10-13 close of $13.49, InfuSystem's $268.7M market cap is priced at a FairStock-calculated P/E of 33.72 and P/B of 4.54. Graham's cautious number is only $5.17, so the margin of safety is -160.93%. That tells me the market is already paying well for the recent profit improvement. The business itself is understandable: it rents and supplies ambulatory infusion pumps and disposables to clinics. The latest filed quarter, fiscal Q2 2026 ended 2026-06-30, showed revenue of $36.9M, net income of $3.2M, and diluted EPS of $0.15. Fiscal Q1 2026 ended 2026-03-31 had revenue of $33.7M, net income of $1.0M, and EPS of $0.05. Fiscal 2025, the year ended 2025-12-31, had revenue of $143.4M, net income of $6.6M, and EPS of $0.31, up from fiscal 2024 net income of $2.3M and EPS of $0.11. So recent profits are moving in the right direction. But the longer record is uneven: the given Lynch category is SLOW GROWER - Shrinking, with profit -17.5% a year over five years and revenue 8.1%. FairStock-calculated ROCE is 7.09%, which is modest, though ROE is 15.03%. Debt/equity is 0.41, Altman Z is 4.11, Piotroski is 7/9, and TTM free cash flow is $12.6M, a 4.7% FCF yield. The moat looks narrow at best: recurring supplies and service relationships help, but I see no evidence of wide pricing power. At 11.03 EV/EBITDA and PEG 1.39, the stock needs continued margin gains to justify the price. FairStock Score is 57/100. I would want proof that the latest profitability is durable, not a one-year bounce.

In plain English: InfuSystem provides infusion pumps and related supplies to clinics and hospitals in the United States and Canada. The business is profitable and has improved recently, but it has grown slowly over longer periods. At the recent close, the stock price looks expensive compared with the company's profits and accounting value.

The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.

Data as of 2026-10-13 close · note generated 2026-10-15 · model deepseek-flash

Sources (SEC EDGAR): fiscal Q2 2026 10-Q (period ended 2026-06-30) · fiscal Q1 2026 10-Q (period ended 2026-03-31) · fiscal Q3 2025 10-Q (period ended 2025-09-30) · fiscal Q2 2025 10-Q (period ended 2025-06-30) · FY2025 10-K (period ended 2025-12-31) · FY2024 10-K (period ended 2024-12-31) · FY2023 10-K (period ended 2023-12-31)

Fundamentals from company filings and market-data providers; prices are end-of-day, not real-time. AI-generated analysis is general and educational — not personal investment advice. Scoring methodology · Score test · Disclaimer